BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29642826)

  • 1. [Investigation of high-risk ST131 clone in ESBL-producing Escherichia coli isolates isolated from urine and non-urinary clinical specimens with MALDI-TOF MS and real time PCR].
    Çizmeci Z; Otlu B; Aktaş E; Ördekçi S; Açıkgöz Ö; Güleç N
    Mikrobiyol Bul; 2018 Jan; 52(1):13-22. PubMed ID: 29642826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A First Insight into Escherichia coli ST131 High-Risk Clone Among Extended-Spectrum Beta-Lactamase-Producing Urine Isolates in Istanbul with the Use of Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass-Spectrometry and Real-Time PCR.
    Aktaş E; Otlu B; Erdemir D; Ekici H; Bulut E
    Microb Drug Resist; 2017 Dec; 23(8):1032-1036. PubMed ID: 28467251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
    Blanco M; Alonso MP; Nicolas-Chanoine MH; Dahbi G; Mora A; Blanco JE; López C; Cortés P; Llagostera M; Leflon-Guibout V; Puentes B; Mamani R; Herrera A; Coira MA; García-Garrote F; Pita JM; Blanco J
    J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and molecular features of sequence type (ST) 131 extended-Spectrum-β-lactamase-producing Escherichia coli in community-onset female genital tract infections.
    Kim YA; Lee K; Chung JE
    BMC Infect Dis; 2018 Jun; 18(1):250. PubMed ID: 29859045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First Report of Prevalence of CTX-M-15-Producing Escherichia coli O25b/ST131 from Iran.
    Namaei MH; Yousefi M; Ziaee M; Salehabadi A; Ghannadkafi M; Amini E; Askari P
    Microb Drug Resist; 2017 Oct; 23(7):879-884. PubMed ID: 28437226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Escherichia coli sequence type 131 by matrix-assisted laser desorption ionization time-of-flight mass spectrometry: implications for infection control policies?
    Lafolie J; Sauget M; Cabrolier N; Hocquet D; Bertrand X
    J Hosp Infect; 2015 Jul; 90(3):208-12. PubMed ID: 25799482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Escherichia coli sequence type 131 clonal group among extended-spectrum β-lactamase-producing E. coli using VITEK MS Plus matrix-assisted laser desorption ionization-time of flight mass spectrometry.
    Matsumura Y; Yamamoto M; Nagao M; Tanaka M; Takakura S; Ichiyama S
    J Microbiol Methods; 2015 Dec; 119():7-9. PubMed ID: 26415529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.
    Yumuk Z; Afacan G; Nicolas-Chanoine MH; Sotto A; Lavigne JP
    J Antimicrob Chemother; 2008 Aug; 62(2):284-8. PubMed ID: 18453527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of extended-spectrum-β-lactamase-producing Escherichia coli ST131 and ST405 clonal groups by matrix-assisted laser desorption ionization-time of flight mass spectrometry.
    Matsumura Y; Yamamoto M; Nagao M; Tanaka M; Machida K; Ito Y; Takakura S; Ichiyama S
    J Clin Microbiol; 2014 Apr; 52(4):1034-40. PubMed ID: 24430452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of CTX-M extended-spectrum beta-lactamases and sequence type 131 in Korean blood, urine, and rectal Escherichia coli isolates.
    Graham SE; Zhang L; Ali I; Cho YK; Ismail MD; Carlson HA; Foxman B
    Infect Genet Evol; 2016 Jul; 41():292-295. PubMed ID: 27101781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of O25b-ST131 clone among Escherichia coli strains producing CTX-M-15, CTX-M-14 and CTX-M-92 β-lactamases.
    Giedraitienė A; Vitkauskienė A; Pavilonis A; Patamsytė V; Genel N; Decre D; Arlet G
    Infect Dis (Lond); 2017 Feb; 49(2):106-112. PubMed ID: 27563748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterisation of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolates from hospital and ambulatory patients in Germany.
    Pietsch M; Eller C; Wendt C; Holfelder M; Falgenhauer L; Fruth A; Grössl T; Leistner R; Valenza G; Werner G; Pfeifer Y;
    Vet Microbiol; 2017 Feb; 200():130-137. PubMed ID: 26654217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic.
    Matsumura Y; Johnson JR; Yamamoto M; Nagao M; Tanaka M; Takakura S; Ichiyama S; ;
    J Antimicrob Chemother; 2015; 70(6):1639-49. PubMed ID: 25687644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of presence of clone ST131 and biofilm formation in ESBL producing and non-producing Escherichia coli strains.
    Celebi D; Aydın E; Rakici E; Baser S; Celebi O; Taghizadehghalehjoughi A
    Mol Biol Rep; 2023 Jul; 50(7):5949-5956. PubMed ID: 37256442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G; Costello M; Pitout JD
    Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain.
    Merino I; Shaw E; Horcajada JP; Cercenado E; Mirelis B; Pallarés MA; Gómez J; Xercavins M; Martínez-Martínez L; De Cueto M; Cantón R; Ruiz-Garbajosa P;
    J Antimicrob Chemother; 2016 Aug; 71(8):2125-30. PubMed ID: 27494832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia.
    Matsumura Y; Nagao M; Iguchi M; Yagi T; Komori T; Fujita N; Yamamoto M; Matsushima A; Takakura S; Ichiyama S
    Clin Microbiol Infect; 2013 Feb; 19(2):161-8. PubMed ID: 22332968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spread of CTX-Type Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates of Epidemic Clone B2-O25-ST131 Among Dogs and Cats in Japan.
    Kawamura K; Sugawara T; Matsuo N; Hayashi K; Norizuki C; Tamai K; Kondo T; Arakawa Y
    Microb Drug Resist; 2017 Dec; 23(8):1059-1066. PubMed ID: 28380311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of extended spectrum-β-lactamase-producing Escherichia coli O25b-ST131: a major community-acquired uropathogen in infants.
    Cheng MF; Chen WL; Hung WY; Huang IF; Chiou YH; Chen YS; Lee SS; Hung CH; Wang JL
    Pediatr Infect Dis J; 2015 May; 34(5):469-75. PubMed ID: 25879646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical epidemiology and molecular analysis of extended-spectrum-β-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648.
    Sherchan JB; Hayakawa K; Miyoshi-Akiyama T; Ohmagari N; Kirikae T; Nagamatsu M; Tojo M; Ohara H; Sherchand JB; Tandukar S
    Antimicrob Agents Chemother; 2015; 59(6):3424-32. PubMed ID: 25824221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.